Cancer

Cancer

Breakthrough in Cancer Immunotherapy: Combinatorial Treatment Significantly Improves Tolerability Without Compromising Efficacy

Current research in cancer immunotherapy has revealed promising results in the administration of recombinant interleukin 2 (IL-2) fusion proteins. However, these treatments are often hindered by dose-limiting toxicities, including vascular leak syndrome. To address this issue, researchers from the University of Zurich have explored the therapeutic potential of co-administering signaling

Cancer

Molecular Iodine Exhibits Differential Antiproliferative Actions in Progenitor and Stem Populations from Chemoresistant Cancer Cells

Researchers at the National Autonomous University of Mexico (UNAM) have discovered that molecular iodine (I) has differential antiproliferative actions on progenitor and stem populations from chemoresistant cancer cells. The study aimed to compare the effect of I supplementation on progenitor and stem populations with low and high invasiveness in mammary